Distinct Influences of Peptide-MHC Quality and Quantity on in Vivo T-Cell

Total Page:16

File Type:pdf, Size:1020Kb

Distinct Influences of Peptide-MHC Quality and Quantity on in Vivo T-Cell Distinct influences of peptide-MHC quality and quantity on in vivo T-cell responses Rachel A. Gottschalka,b, Matthew M. Hathornb,c,1, Hélène Beuneud,1, Emily Corsea, Michael L. Dustind, Grégoire Altan-Bonnetc, and James P. Allisona,2 aDepartment of Immunology, Howard Hughes Medical Institute, and Ludwig Center for Cancer Immunotherapy, Memorial Sloan-Kettering Cancer Center, New York, NY 10065; bImmunology and Microbial Pathogenesis Program, Weill Cornell Graduate School of Medical Sciences, New York, NY 10021; cPrograms in Computational Biology and Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY 10065; and dProgram in Molecular Pathogenesis, Helen L. and Martin S. Kimmel Center for Biology and Medicine of the Skirball Institute of Biomolecular Medicine, New York University School of Medicine, New York, NY 10016 Contributed by James P. Allison, December 9, 2011 (sent for review September 12, 2011) The strength of T-cell receptor (TCR) stimulation and subsequent strong pMHC). We used two previously characterized 5C.C7 T-cell response depend on a combination of peptide-major histo- TCR ligands presented in the context of I-Ek: moth cytochrome c compatibility complex (pMHC) density and potency. By comparing peptide 88–103 (MCC) (9) and 102S, a weak agonist peptide two different pMHC at doses yielding similar proliferation in vivo, resulting from an amino acid substitution at a single TCR contact we have highlighted unexpected differences in the qualitative and residue (10). The half-life of pMHC/TCR interactions is shorter quantitative effects of TCR ligand. Measurements of cytokine sen- for 102S than for MCC, as measured by either tetramer dissoci- – – sitivity and two-photon imaging of T cell dendritic cell (T DC) ation (t1/2 =33± 0.4 and 188.1 s, respectively) (8) or as calculated interactions reveal discrimination between comparably weak stim- from monomeric surface plasmon resonance measurements of uli resulting from either decreased pMHC potency or pMHC den- off-rate (t1/2 = 0.82 and 5.77 s, respectively) (11). sity. In addition, TCR-induced genes in broad gene expression Our results provide unique in vivo evidence for discrimination of profiles segregate into two groups: one that responds to cumula- pMHC potency, independent of the cumulative level of TCR signal, tive TCR signal and another that responds to pMHC quality, in- clearly demonstrating distinct influences of pMHC quality and dependent of quantity. These observations suggest that models quantity. Although pMHC density and potency appear interchange- IMMUNOLOGY of TCR ligand discrimination must account for disparate sensitivity able in the induction of proliferation in vivo, there are specific of downstream responses to specificinfluences of pMHC potency. effects of pMHC potency on the regulation of the IL-2 pathway. Furthermore, two-photon imaging indicates that T cells respond to affinity | IL-2 | STAT5 comparably weak low-potency and low-density stimuli in the context of distinct T cell–dendritic cell (T–DC) interactions. Finally, broad cells recognize peptide antigen in the context of MHC. gene expression patterns reveal a segregation of TCR-induced T During this process, the quality and quantity of the ligands responses into two groups: one that responds to the cumulative level determine the cumulative level of downstream signaling. Evi- of TCR signal and one that is sensitive to pMHC potency inde- dence suggests that T-cell receptor (TCR) can detect pMHC pendent of ligand density. Together these findings inform improved with remarkable sensitivity, responding to fewer than 10 pMHC models of TCR ligand discrimination and highlight the importance complexes (1, 2), and several models of TCR triggering have of distinguishing between pMHC density and potency during the been proposed to explain the ability of TCR to recognize various design of experimental systems and immunotherapies. pMHC ligands with such sensitivity, above the noise of abundant self-pMHC (3). Both TCR/pMHC affinity and off-rate can cor- Results relate with the potency of stimulation, depending on the on-rate of Peptide-MHC Density Can Compensate for Potency in the Induction the ligand (4, 5). Thus, the diverse nature of TCR/pMHC binding of Proliferation in Vivo. In vivo T-cell proliferation is influenced properties may limit the applicability of characterizing ligand by both pMHC density and potency (12). We addressed the re- quality on the basis of any single biochemical or thermodynamic lationship between these two variables in the initiation of pro- parameter. Here we use the term potency to more generally reflect liferation by titrating two previously characterized peptide ligands qualitative differences in TCR/pMHC binding parameters. for the 5C.C7 TCR. The natural ligand, MCC peptide, behaves as It is known from in vitro studies that the strength of TCR/ a strong agonist both in vitro and in vivo (8, 9), whereas 102S pMHC interactions sets dose requirements for initiation of a va- peptide, with both a lower affinity and a shorter half-life of TCR/ riety of T-cell responses (6). Higher peptide concentrations can pMHC–tetramer interactions, has a higher in vitro EC50 and results often compensate for weaker TCR/pMHC interactions to yield in decreased proliferation, cytokine production, and memory for- equivalent maximal responses in vitro. Thus, in studying the ef- mation in vivo (8, 10, 11). Both peptides bind comparably to MHC fects of altering the individual components of cumulative TCR (13) and are cleared at a similar rate in vivo (14). Consistent signal (i.e., the potency or density of antigen), it is difficult to with our previous work (14), in vivo titrations of stimulating peptide discriminate between distinct influences of TCR/pMHC binding demonstrated that pMHC potency shifts the threshold for pro- parameters and the impact of shifting the overall TCR signal. For liferation without altering the sharpness of the proliferative example, whereas recent in vivo studies have demonstrated that altered TCR ligands can induce large differences in the degree of proliferation, cytokine production and memory formation (7, 8), Author contributions: R.A.G., M.M.H., H.B., E.C., and G.A.-B. designed research; R.A.G., it is unclear whether the observed functional consequences are M.M.H. and H.B. performed research; R.A.G., M.M.H., H.B., E.C., M.L.D., G.A.-B., and J.P.A. specific to qualitative differences in these ligands or could be analyzed data; and R.A.G. and J.P.A. wrote the paper. similarly influenced by the amount of antigen. Only by manipu- The authors declare no conflict of interest. lating both variables within the same system is it possible to de- Freely available online through the PNAS open access option. termine whether T cells can discern specificinfluences of pMHC 1M.M.H. and H.B. contributed equally to this work. quality and quantity. Thus, we compared weak stimuli in vivo, 2To whom correspondence should be addressed. E-mail: [email protected]. resulting from either decreased pMHC potency (large quantities This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. of weak pMHC) or decreased pMHC density (small quantities of 1073/pnas.1119763109/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1119763109 PNAS Early Edition | 1of6 Downloaded by guest on September 26, 2021 A C of 102S and MCC resulting in comparable proliferation also yielded similar Akt phosphorylation and induction of Foxp3 (14). After 48 h of in vivo stimulation, adoptively transferred 5C.C7 T cells were isolated and stained for the proliferation antigen ki67. We determined stimulation conditions, referred to here as “high-dose” (2 μg) 102S and “low-dose” (0.2 μg) MCC, which induced comparable proliferation, consistently resulting in ex- pression of ki67 in fewer than half of 5C.C7 T cells (Fig. 1 B and C). Using these conditions, we compared weak stimuli resulting from either reduced pMHC potency or reduced pMHC density. Peptide-MHC Potency Dissociates IL-2 Sensitivity, Receptor Expression, and Production from Cumulative TCR Signal. In seeking functional responses differentially regulated by TCR ligand quality and quantity, the IL-2 pathway was of particular interest in light of our previous work, which indicated differential survival induced by B low-density and low-potency pMHC (14). In addition, the IL-2 pathway has known antiapoptotic properties (15, 16) and is reg- ulated by a variety of factors downstream of the TCR (17). Thus, we assessed the effects of pMHC potency and density on TCR- induced IL-2 sensitivity. 5C.C7 T cells were isolated from lymph nodes (LNs) 48 h after injection of high- or low-dose MCC or 102S. The T cells were then stripped of bound cytokine and briefly treated with varying doses of IL-2, before fixing and staining for phosphorylated STAT5 as a measure of responsiveness to IL-2. Fig. 1. Peptide-MHC density can compensate for potency in the induction of Compared with 102S-stimulated 5C.C7, both doses of MCC proliferation in vivo. Adoptively transferred 5C.C7 T cells were isolated from LNs resulted in increased IL-2 sensitivity (Fig. 2). High-dose 102S in- 48 h after injection of (A) a 10-fold titration or (B and C)high(2μg) or low (0.2 duced some sensitivity to IL-2; however, the amplitude of this re- μg) doses of MCC or 102S peptide. (A) Percentage of cells that had divided was B fl C sponse was reduced compared with cells responding to low-dose assessed using dilution of CFSE. ( ) Representative ow plots and ( ) pooled MCC (Fig. 2B). Thus, compared with the proliferative response frequencies of ki67 expression. Shaded histograms represent the no-peptide control. Data are representative of at least three independent experiments. (Fig. 1), increased pMHC density was unable to compensate for the low potency of the 102S ligand in terms of responsiveness to IL-2.
Recommended publications
  • The Title of the Dissertation
    UNIVERSITY OF CALIFORNIA SAN DIEGO Novel network-based integrated analyses of multi-omics data reveal new insights into CD8+ T cell differentiation and mouse embryogenesis A dissertation submitted in partial satisfaction of the requirements for the degree Doctor of Philosophy in Bioinformatics and Systems Biology by Kai Zhang Committee in charge: Professor Wei Wang, Chair Professor Pavel Arkadjevich Pevzner, Co-Chair Professor Vineet Bafna Professor Cornelis Murre Professor Bing Ren 2018 Copyright Kai Zhang, 2018 All rights reserved. The dissertation of Kai Zhang is approved, and it is accept- able in quality and form for publication on microfilm and electronically: Co-Chair Chair University of California San Diego 2018 iii EPIGRAPH The only true wisdom is in knowing you know nothing. —Socrates iv TABLE OF CONTENTS Signature Page ....................................... iii Epigraph ........................................... iv Table of Contents ...................................... v List of Figures ........................................ viii List of Tables ........................................ ix Acknowledgements ..................................... x Vita ............................................. xi Abstract of the Dissertation ................................. xii Chapter 1 General introduction ............................ 1 1.1 The applications of graph theory in bioinformatics ......... 1 1.2 Leveraging graphs to conduct integrated analyses .......... 4 1.3 References .............................. 6 Chapter 2 Systematic
    [Show full text]
  • Modulating Hallmarks of Cholangiocarcinoma
    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Fall 12-14-2018 Modulating Hallmarks of Cholangiocarcinoma Cody Wehrkamp University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Part of the Molecular Biology Commons Recommended Citation Wehrkamp, Cody, "Modulating Hallmarks of Cholangiocarcinoma" (2018). Theses & Dissertations. 337. https://digitalcommons.unmc.edu/etd/337 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. MODULATING HALLMARKS OF CHOLANGIOCARCINOMA by Cody J. Wehrkamp A DISSERTATION Presented to the Faculty of the University of Nebraska Graduate College in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Biochemistry and Molecular Biology Graduate Program Under the Supervision of Professor Justin L. Mott University of Nebraska Medical Center Omaha, Nebraska November 2018 Supervisory Committee: Kaustubh Datta, Ph.D. Melissa Teoh‐Fitzgerald, Ph.D. Richard G. MacDonald, Ph.D. Acknowledgements This endeavor has led to scientific as well as personal growth for me. I am indebted to many for their knowledge, influence, and support along the way. To my mentor, Dr. Justin L. Mott, you have been an incomparable teacher and invaluable guide. You upheld for me the concept that science is intrepid, even when the experience is trying. Through my training, and now here at the end, I can say that it has been an honor to be your protégé. When you have shaped your future graduates to be and do great, I will be privileged to say that I was your first one.
    [Show full text]
  • Klf5 Is Involved in Self-Renewal of Mouse Embryonic Stem Cells
    Short Report 2629 Klf5 is involved in self-renewal of mouse embryonic stem cells Silvia Parisi1,2,*, Fabiana Passaro1,3,*, Luigi Aloia1,2, Ichiro Manabe4, Ryozo Nagai5, Lucio Pastore1,3 and Tommaso Russo1,3,‡ 1CEINGE Biotecnologie Avanzate, 80145 Napoli, Italy 2European School of Molecular Medicine, SEMM, 80145 Napoli, Italy 3Dipartimento di Biochimica e Biotecnologie Mediche, Università di Napoli Federico II, 80131 Napoli, Italy 4Nano-Bioengineering Education Program and 5Department of Cardiovascular Medicine, The University of Tokyo Graduate School of Medicine, 7-3-1 Hongo, Bunkyo, Tokyo 113-8655, Japan *These authors contributed equally to this work ‡Author for correspondence (e-mail: [email protected]) Accepted 15 May 2008 Journal of Cell Science 121, 2629-2634 Published by The Company of Biologists 2008 doi:10.1242/jcs.027599 Summary Self-renewal of embryonic stem cells (ESCs) is maintained by undifferentiated state by Klf5 is, at least in part, due to the a complex regulatory mechanism involving transcription factors control of Nanog and Oct3/4 transcription, because Klf5 directly Oct3/4 (Pou5f1), Nanog and Sox2. Here, we report that Klf5, a binds to the promoters of these genes and regulates their Zn-finger transcription factor of the Kruppel-like family, is transcription. involved in ESC self-renewal. Klf5 is expressed in mouse ESCs, blastocysts and primordial germ cells, and its knockdown by RNA interference alters the molecular phenotype of ESCs, Supplementary material available online at thereby preventing their correct differentiation. The ability of http://jcs.biologists.org/cgi/content/full/121/16/2629/DC1 Klf5 to maintain ESCs in the undifferentiated state is supported by the finding that differentiation of ESCs is prevented Key words: Differentiation, Kruppel-like factors, Nanog, Oct3/4, when Klf5 is constitutively expressed.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,067,617 B2 Barbas, III Et Al
    US007067617B2 (12) United States Patent (10) Patent No.: US 7,067,617 B2 Barbas, III et al. (45) Date of Patent: Jun. 27, 2006 (54) ZINC FINGER BINDING DOMAINS FOR OTHER PUBLICATIONS NUCLEOTDE SEOUENCE ANN Q Nagase et al., DNA Research, 2000, vol. 7, pp. 271-281.* (75) Inventors: Carlos F. Barbas, III, Solana Beach, Zweidler-McKay, et al ... “Gifi-1 Encodes a Nuclear Zinc CA (US); Birgit Dreier, Adlikon (CH) Finger Protein That Binds DNA and Functions as a Tran s s scriptional Repressor, Mol. Cell. Biol. 16: 4024-4034 (73) Assignee: The Scripps Research Institute, La (1996). Jolla, CA (US) Dreier, et al., “Insights into the Molecular Recogntion of the s 5-GNN-3 Family of Sequences by Zinc Finger Domains’. (*) Notice: Subject to any disclaimer, the term of this J. Mol. Biol. 303: 489-502 (2000). patent is extended or adjusted under 35 Celenza, et al., “A Yeast Gene That is Essential for Release U.S.C. 154(b) by 115 days. from Glucose Repression Encodes a Protein Kinase”, Sci ence 233: 1175-1180 (1986). (21) Appl. No.: 10/080,100 Singh, et al., “Molecular Cloning of an Enhancer Binding Protein: Isolation by Screening of an Expression Library (22) Filed: Feb. 21, 2002 with a Recognition Site DNA”, Cell 52: 415-423 (1988). Kinzler, et al., “The GLI Gene is a Member of the Kruppel (65) Prior Publication Data Family of Zinc Finger Proteins”, Nature 332: 371-374 US 20O2/O165356 A1 Nov. 7, 2002 (1988). OV. f. Debs, et al., “Regulation Gene Expression in Vivo by Related U.S.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,790,941 B2 Barbas, III Et Al
    USOO6790941B2 (12) United States Patent (10) Patent No.: US 6,790,941 B2 Barbas, III et al. (45) Date of Patent: *Sep. 14, 2004 (54) ZINC FINGER PROTEIN DERIVATIVES AND 5,702.914. A 12/1997 Evans et al. METHODS THEREFOR 5,789,538 A * 8/1998 Rebar et al. ................ 530/324 5,792,640 A 8/1998 Chandrasegaran (75) Inventors: Carlos F. Barbas, III, San Diego, CA 5,869,618 A 2/1999 Lippman et al. (US); Joel M. Gottesfeld, Del Mar, CA 5,871,902 A 2/1999 Weininger et al. (US); Peter E. Wright, La Jolla, CA 5,871,907 A 2/1999 Winter et al. s s s 5,916,794. A 6/1999 Chandrasegaran (US) 5,939,538 A 8/1999 Leavitt et al. (73) Assignee: The Scripps Research Institute, La 6,001.885. A 12/1999 Vega et al. Jolla, CA (US) 6,007,988 A 12/1999 Choo et al. s 6,013,453 A 1/2000 Choo et al. ( c: ) Notice: Subject to any disclaimer, the term of this 6.242,568 B1 6/2001 Barbas et al. ............... 530/350 patent is extended or adjusted under 35 2002/0081.614 A1 6/2002 Case et al. U.S.C. 154(b) by 0 days. FOREIGN PATENT DOCUMENTS This patent is Subject to a terminal dis- WOEP WO95/19431875567 11/1998y: claimer. WO WO 96/06110 2/1996 WO WO 96/06166 2/1996 (21) Appl. No.: 09/500,700 WO WO 96/11267 4/1996 22) Filled: Feb. 9,9 2000 WO WO 96/20951 7/1996 (65) Prior Publication Data W W o: 19.
    [Show full text]
  • Pediatric Dermatology at the IID 2013 Wednesday, May 8Th, 9 Am to Noon Sidlaw Room at the Edinburgh International Conference Centre
    Pediatric Dermatology at the IID 2013 Wednesday, May 8th, 9 am to noon Sidlaw Room at the Edinburgh International Conference Centre 9:00-9:18 am Introduction/Roadmap review: Co-chairs Amy Paller, MS, MD, Northwestern University, Chicago, IL USA Alan Irvine, MD, Trinity College, Dublin, Ireland Masashi Akiyama, MD, PhD, Nagoya University, Nagoya, Japan 9:18-9:48 am Are there stem cells in the dermis? Fiona Watt, PhD, King's College, London, UK 9:48-10:00 am Abstract presentation #796: Molecular identification of collagen 17α1 as a major genetic modifier of epidermolysis bullosa in mice John Sundberg, PhD, Jackson Laboratories, Bar Harbor, Maine, USA 10:00-10:30 am Long noncoding RNAs and human diseases Howard Chang, MD, PhD, Stanford University, Stanford, California, USA 10:36-10:48 am Abstract presentation #757: Production of gene engineered epithelia sheets for first-in-man use Wei-Li Di, MBBS, PhD, University College London, London, U.K. 10:48-11:18 am Venous malformations: From pathogenesis to an animal model for therapeutic trials Miikka Vikkula, MD, PhD, Catholic University of Louvain, Brussels, Belgium 11:18-11:30 am Abstract presentation #813: Identification of a hyperkeratosis “signature” in lamellar ichthyosis: Mdm2 inhibition prevents hyperkeratosis in lamellar ichthyosis models Gehad Youssef, MRes, University College London, London, U.K. 11:30-12:00 pm Pediatric skin microbiome and atopic dermatitis Julie Segre, PhD, National Institutes of Health, Bethesda, MD, USA Thanks to the IID Pediatric Dermatology Committee: Amy Paller, Alan Irvine, and Masashi Akiyama, Chairs; Members: Keith Choate, Jon Dyer, John Harper, Al Lane, John McGrath, Jonathan Silverberg, Alain Taieb, Katsuto Tamai, Joyce Teng, Antonio Torrelo; and the administrative assistance of Lynn Janke.
    [Show full text]
  • Development of Zinc Finger Domains for Recognition of the 5؅-ANN-3؅ Family of DNA Sequences and Their Use in the Construction of Artificial Transcription Factors*
    THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 276, No. 31, Issue of August 3, pp. 29466–29478, 2001 © 2001 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A. Development of Zinc Finger Domains for Recognition of the 5؅-ANN-3؅ Family of DNA Sequences and Their Use in the Construction of Artificial Transcription Factors* Received for publication, March 22, 2001 Published, JBC Papers in Press, May 4, 2001, DOI 10.1074/jbc.M102604200 Birgit Dreier‡, Roger R. Beerli§, David J. Segal, Jessica D. Flippin, and Carlos F. Barbas III¶ From The Skaggs Institute for Chemical Biology and the Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037 In previous studies we have developed Cys2-His2 zinc used to purposefully regulate gene expression. We have dem- finger domains that specifically recognized each of the onstrated that gene expression can be specifically altered 5؅-GNN-3؅ DNA target sequences and could be used to through the use of designed polydactyl zinc finger transcription 16 assemble six-finger proteins that bind 18-base pair DNA factors that bind 18 base pairs (bp)1 of DNA sequence. Because sequences (Beerli, R. R., Dreier, B., and Barbas, C. F., III of their extended DNA recognition site, these proteins have the (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 1495–1500). Such potential to be genome-specific transcriptional regulators (1, 2). proteins provide the basis for the construction of artifi- Targeting of only 9 bp of sequence can also result in gene cial transcription factors to study gene/function rela- regulation wherein chromatin structure provides for an addi- tionships in the post-genomic era.
    [Show full text]
  • Table S1. the Statistical Metrics for Key Differentially Expressed Genes (Degs)
    Table S1. The statistical metrics for key differentially expressed genes (DEGs) Gene Agilent Id Symbol logFC pValue FDR tvalue Regulation Gene Name oxidized low density lipoprotein A_24_P124624 OLR1 2.458429 1.19E-13 7.25E-10 24.04241 Up receptor 1 A_23_P90273 CHST8 2.622464 3.85E-12 6.96E-09 19.05867 Up carbohydrate sulfotransferase 8 A_23_P217528 KLF8 2.109007 4.85E-12 7.64E-09 18.76234 Up Kruppel like factor 8 A_23_P114740 CFH 2.651636 1.85E-11 1.79E-08 17.13652 Up complement factor H A_23_P34031 XAGE2 2.000935 2.04E-11 1.81E-08 17.02457 Up X antigen family member 2 A_23_P27332 TCF4 1.613097 2.32E-11 1.87E-08 16.87275 Up transcription factor 4 histone cluster 1 H1 family A_23_P250385 HIST1H1B 2.298658 2.47E-11 1.87E-08 16.80362 Up member b abnormal spindle microtubule A_33_P3288159 ASPM 2.162032 2.79E-11 2.01E-08 16.66292 Up assembly H19, imprinted maternally expressed transcript (non-protein A_24_P52697 H19 1.499364 4.09E-11 2.76E-08 16.23387 Up coding) potassium voltage-gated channel A_24_P31627 KCNB1 2.289689 6.65E-11 3.97E-08 15.70253 Up subfamily B member 1 A_23_P214168 COL12A1 2.155835 7.59E-11 4.15E-08 15.56005 Up collagen type XII alpha 1 chain A_33_P3271341 LOC388282 2.859496 7.61E-11 4.15E-08 15.55704 Up uncharacterized LOC388282 A_32_P150891 DIAPH3 2.2068 7.83E-11 4.22E-08 15.5268 Up diaphanous related formin 3 zinc finger protein 185 with LIM A_23_P11025 ZNF185 1.385721 8.74E-11 4.59E-08 15.41041 Up domain heat shock protein family B A_23_P96872 HSPB11 1.887166 8.94E-11 4.64E-08 15.38599 Up (small) member 11 A_23_P107454
    [Show full text]
  • And Stage-Specific Expression of Otx2 Is Regulated by Multiple Transcription Factors and Cis-Regulatory Modules in the Retina Candace S
    © 2020. Published by The Company of Biologists Ltd | Development (2020) 147, dev187922. doi:10.1242/dev.187922 RESEARCH ARTICLE Cell type- and stage-specific expression of Otx2 is regulated by multiple transcription factors and cis-regulatory modules in the retina Candace S. Y. Chan1, Nicolas Lonfat2, Rong Zhao2, Alexander E. Davis1, Liang Li1,3, Man-Ru Wu1, Cheng-Hui Lin1, Zhe Ji4, Constance L. Cepko2,* and Sui Wang1,* ABSTRACT function. The re-use of a limited pool of TFs in different cellular Transcription factors (TFs) are often used repeatedly during contexts probably evolved to maximize their utility in driving the development and homeostasis to control distinct processes in the evolution of an amazingly diverse set of cell types and functions. A same and/or different cellular contexts. Considering the limited number full definition of how specificity and function are created through the of TFs in the genome and the tremendous number of events that need redeployment of TFs is an area of interest in many systems. to be regulated, re-use of TFs is necessary. We analyzed how the The vertebrate neural retina has served as a model system for expression of the homeobox TF, orthodenticle homeobox 2 (Otx2), is studying the development of a complex mammalian tissue (Cepko in vivo regulated in a cell type- and stage-specific manner during development et al., 1996). Access to the developing retina using in the mouse retina. We identified seven Otx2 cis-regulatory modules electroporation has provided a strong platform for studies of gene (CRMs), among which the O5, O7 and O9 CRMs mark three distinct regulation and cell fate determination (Matsuda and Cepko, 2007, cellular contexts of Otx2 expression.
    [Show full text]
  • The Application of Transcriptomics in the Comparative Safety Assessment of (GMO-Derived) Plant Products
    The application of transcriptomics in the comparative safety assessment of (GMO-derived) plant products E.J. Kok Promotoren Prof. dr. ir. I.M.C.M. Rietjens Hoogleraar Toxicologie, Wageningen Universiteit Prof. dr. M.R. Müller Hoogleraar Voeding, Metabolisme en Genomics, Wageningen Universiteit Co-promotoren Dr. ir. H.A. Kuiper Onderzoeker, RIKILT – Instituut voor Voedselveiligheid, Wageningen Prof. dr. ir. J. Keijer Groepshoofd, RIKILT – Instituut voor Voedselveiligheid, Wageningen Promotiecommissie Prof. dr. R.J. Bino (Wageningen Universiteit) Prof. dr. H.V. Davies (Scottish Crop Research Institute, Dundee, UK) Prof. dr. W.J. Stiekema (Wageningen Universiteit) Prof. dr. W.M. de Vos (Wageningen Universiteit) Dit onderzoek is uitgevoerd binnen de onderzoeksschool VLAG The application of transcriptomics in the comparative safety assessment of (GMO-derived) plant products Esther Jeannette (van Leeuwe-) Kok Proefschrift ter verkrijging van de graad van doctor op gezag van de Rector Magnificus van Wageningen Universiteit, Prof. dr. M.J. Kropff, in het openbaar te verdedigen op vrijdag 13 juni 2008 des morgens te elf uur in de Aula Esther Kok The application of transcriptomics in the comparative safety assessment of (GMO-derived) plant products PhD thesis Wageningen University and Research Centre, the Netherlands With summaries in English and Dutch. ISBN 978-90-8504-929-6 Aan mijn vader† en moeder, Sarina† en Carolien Abstract National and international organizations have discussed current approaches to the safety assessment of complex (plant) food products in general and the safety assessment of GMO- derived food products in particular. One of the recommendations of different expert meetings was that the new analytical techniques, in particular the ‘omics’ approaches, need to be explored for their potential to improve the analysis and thereby the toxicological and nutritional assessment of complex (GMO-derived) plant products.
    [Show full text]
  • Long Non‑Coding RNA PCED1B‑AS1 Promotes Pancreatic Ductal Adenocarcinoma Progression by Regulating the Mir‑411‑3P/HIF‑1Α Axis
    ONCOLOGY REPORTS 46: 134, 2021 Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis YI ZHANG1, HUAN MA2 and CHANG CHEN1 1Department of Gastroenterology, The People's Hospital of China Three Gorges University and The First People's Hospital of Yichang, Yichang, Hubei 443000; 2Department of Gastroenterology, Qingdao Municipal Hospital, Qingdao, Shandong 266000, P.R. China Received September 24, 2020; Accepted February 18, 2021 DOI: 10.3892/or.2021.8085 Abstract. An increasing number of studies have shown that Introduction long non‑coding RNAs (lncRNAs) are crucially involved in tumorigenesis. However, the biological functions, underlying Pancreatic cancer has a 5‑year survival rate less than 8% and is mechanisms and clinical value of lncRNA PC‑esterase domain one of the deadliest types of cancer worldwide. Pancreatic ductal containing 1B‑antisense RNA 1 (PCED1B‑AS1) in pancreatic adenocarcinoma (PDAC) is the most common pathological type ductal adenocarcinoma (PDAC) have not been determined, to of pancreatic cancer (1‑4). For patients with advanced stage the best of our knowledge. In the present study, the expression of PDAC, therapeutic options are limited, and their prognosis is PCED1B‑AS1, microRNA (miR)‑411‑3p and hypoxia inducible extremely poor (1‑4). Thus, there is an urgent need to improve factor (HIF)‑1α mRNA in 47 cases of PDAC tissues were detected the current understanding of the mechanisms underlying using reverse transcription‑quantitative (RT‑q)PCR. Moreover, progression of PDAC to identify novel therapeutic targets. the effects of PCED1B‑AS1 on the biological behaviors of PDAC Long non‑coding RNAs (lncRNAs) are a type of RNA cells were assessed using Cell Counting Kit‑8, EdU staining and molecule of >200 nucleotides in length, which have limited or Transwell assays.
    [Show full text]
  • The Mutational Burden and Oligogenic
    Li et al. BMC Musculoskeletal Disorders (2020) 21:220 https://doi.org/10.1186/s12891-020-03229-x RESEARCH ARTICLE Open Access The mutational burden and oligogenic inheritance in Klippel-Feil syndrome Ziquan Li1,2,3, Sen Zhao1,2, Siyi Cai1, Yuanqiang Zhang1,2,3, Lianlei Wang1,2,3, Yuchen Niu2,4, Xiaoxin Li2,4, Jianhua Hu1, Jingdan Chen2, Shengru Wang1, Huizi Wang2, Gang Liu1,2, Ye Tian1, Zhihong Wu2,4, Terry Jianguo Zhang1,2,5, DISCO (Deciphering Disorders Involving Scoliosis and COmorbidities) study, Yipeng Wang1,2,5* and Nan Wu1,2,5* Abstract Background: Klippel-Feil syndrome (KFS) represents a rare anomaly characterized by congenital fusion of the cervical vertebrae. The underlying molecular etiology remains largely unknown because of the genetic and phenotypic heterogeneity. Methods: We consecutively recruited a Chinese cohort of 37 patients with KFS. The clinical manifestations and radiological assessments were analyzed and whole-exome sequencing (WES) was performed. Additionally, rare variants in KFS cases and controls were compared using genetic burden analysis. Results: We primarily examined rare variants in five reported genes (GDF6, MEOX1, GDF3, MYO18B and RIPPLY2) associated with KFS and detected three variants of uncertain significance in MYO18B. Based on rare variant burden analysis of 96 candidate genes related to vertebral segmentation defects, we identified BAZ1B as having the highest probability of association with KFS, followed by FREM2, SUFU, VANGL1 and KMT2D. In addition, seven patients were proposed to show potential oligogenic inheritance involving more than one variants in candidate genes, the frequency of which was significantly higher than that in the in-house controls.
    [Show full text]